The Hyderabad based global vaccine maker Bharat Biotech International Limited announced that its INCOVAC (BBV154), its COVID-19 vaccine in the form of nasal drops, has received approval from the Central Drugs Standard Control Organisation…
It has been learnt that the Drug Controller General of India (DCGI) has given emergency permission to use the vaccine "Incovac" , a drop medicine developed by Bharat Biotech, as a booster dose for the Covid-19 disease.
Bharat Biotech today announced that BBV152 (Covaxin), its whole-virion inactivated Covid-19 vaccine candidate, has proven to be safe, well-tolerated, and immunogenic in paediatric subjects in phase II/III study.
Bharat Biotech had…
The Drug Controller General of India (DCGI) on Saturday approved Covaxin for emergency use for children above 12 years. The approval is for children between 12 to 18 years of age only. The vaccine is not for children below 12 years.
…